AzTrials
AzTrials

Primary InfertilityFreezingNCT01271400

LANDA Embryo Freezing Technique.

An observational study of Primary Infertility and Secondary Infertility, run by West Coast Fertility Centers at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to track the outcome from the patients who had embryo cryopreservation as part of their Advanced Reproductive Technology (ART) treatment at West Coast Fertility Centers. Read more about this study

Who is it for?
Ages 21 to 37 years, women onlyHealthy volunteers can take part
How many people
20 participants
Where
1 siteUnited States
Study dates
Dec 2010to Jan 2012
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 37 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: Infertility patients

Who may be able to join

  • To be eligible for inclusion into this study, each subject must satisfy the following criteria:
  • Infertile women whose physician has recommended IVF and who agree to cryopreserve surplus embryos.
  • Cancer patients who wish to preserve their fertility prior to cancer treatments.
  • Recipients who wish to use frozen donor embryos.
  • A male partner whose semen analysis meets the clinic criteria for ICSI. Use of donor sperm is also acceptable.
  • Be willing and able to comply with the protocol for the duration of the study.
  • Have voluntarily provided written informed consent under WIRB.

Who cannot join

  • A patient may NOT be entered into the study if she presents with ANY of the following criteria:
  • Clinically significant systemic disease.
  • Known endometriosis Grade III - IV (ASRM classification).
  • Any previous cycle indicating a low response to gonadotropin stimulation (defined as retrieval of < 10 eggs at retrieval)
  • Three or more previous ART cycles without a clinical pregnancy
  • Abnormal, undiagnosed, gynecological bleeding.
Show all 12Show fewer
  • Previous ovarian surgery
  • Known allergy or hypersensitivity to recombinant gonadotropin preparations or any other study-related medications.
  • Verifiable substance abuse.
  • Simultaneous participation in another study protocol.
  • Current smoker.
  • An extrauterine pregnancy within the last 3 months before OCP treatment commences.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • West Coast Fertility Centers

    Fountain Valley, California, 92708

Other trials in United States

About this study

Official title: Use of the LANDA Embryo Freezing Technique to Validate Frozen Embryo Transfer Success Rates

The aim of this study is to track the outcome from the patients who had embryo cryopreservation as part of their Advanced Reproductive Technology (ART) treatment at West Coast Fertility Centers.

Read the detailed description

Over the past several decades, considerable effort has been expended toward the successful cryopreservation of various human cells. While attempts at cryopreservation have been directed at different tissue types, one of the most vigorously pursued targets has been reproductive tissue. Historically, cryopreservation of human sperm has existed for several decades. The earliest reports of pregnancies (Trounson et al., 1983) and births (Zeilmaker et al., 1984) from the cryopreservation of human embryos occurred in the early 1980s. Presently, the freezing and storage of human embryos following in vitro fertilization (IVF) is standard practice at most fertility clinics. In 2003, the CDC Assisted Reproductive Technology success rates report stated that 4,246 live births occurred out of 17,517 non-donor frozen embryo cycles.

Embryo cryopreservation has been a routine component of clinical IVF programs for more than 2 decades but has a relatively poor outcome in terms of post-thaw survival and pregnancy rates in a majority of IVF programs. Efficient embryo cryopreservation has several advantages. It helps to reduce costs and increases cumulative pregnancy rates. It can also help in cases of IVF cycles where embryos are not transferred due to ovarian hyper stimulation syndrome. It is also useful when technical difficulties are encountered at the time of an embryo transfer procedure.

One of the major concerns in IVF is high-order multiple pregnancies, which result from the transfer of multiple embryos in a given cycle. In the last 5 years, improved stimulation protocols, advances in culture and laboratory systems, and better identification of viable embryos have enhanced the success rates of IVF. During the same period, some clinics have started the practice of transferring two embryos to reduce multiple pregnancy rates without compromising overall pregnancy rates.

Furthermore, in recent years some European countries, particularly the Scandinavian countries, have taken a lead in performing elective single-embryo transfers and have achieved acceptable pregnancy rates. This trend is spreading to other countries. This can result in surplus embryos being available for freezing. With the application of ICSI, even patients aged 40 years or older may have embryos to freeze.

Review of the current literature reveals modest post-thaw embryo survival, implantation, and pregnancy rates. Post-thaw survival rates vary from 50% to 80% for different embryo stages. Implantation and pregnancy rates have varied from 3% to 15% and 15% to 25% respectively, which is approximately half of the rates achieved for fresh embryo transfers.

To improve the outcome of frozen ET cycles, we modified various steps of our standard cryopreservation protocol. In a pilot study on arrested and fragmented embryos (grades 3 and 4), we achieved post-thaw survival rates of 92%, having all blastomeres intact. Encouraged by the post-thaw survival of these embryos; we propose using this modified protocol in our frozen embryo transfer program.

Keywords
Infertility treatments, Frozen embryo transfers (FET)., IVF., ART., Cryopreservation, Slow-Freeze, Freeze / thaw survival rates, Blastocyst formation, Pregnancy
Medical subject headings
Genital Diseases, Male, Genital Diseases, Female

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Freeze/Thawed survival rates

    • Freeze / thaw survival rates
    • Blastocyst formation rates
    • Pregnancy rate.

    Measured: When embryos thawed initiate

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jan 2011 (estimated)
  2. Study startDec 2010
  3. Primary completionJan 2012 (estimated)
  4. Study completionJan 2012 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01271400
Sponsor's protocol ID
2010-1
Acronym
Freezing
Status last verified
Sep 2011
First submitted
5 Jan 2011
Last updated
8 Sep 2011
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Primary Infertility and Secondary Infertility, run by West Coast Fertility Centers at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Sep 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Freeze/Thawed survival rates (time frame: When embryos thawed initiate). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2011.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in